Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ) (XVIPF) Stock Forecast & Price Predictions
Get the latest Xvivo Perfusion AB (publ) (XVIPF) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Xvivo Perfusion AB (publ) Stock Forecast Summary
Xvivo Perfusion AB (publ) (XVIPF) stock is currently priced at $19.30. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $19.61.
In the long term, XVIPF shows a bullish trend. The 2027 forecast points to $30.61 (58.61% change), while the 2031 forecast suggests $33.65 (74.36% change). Looking 7 years ahead, projections estimate the stock could trade near $34.28, a 77.63% change from today’s price.
Bullish
Bullish
Bullish
This mix indicates that Xvivo Perfusion AB (publ) stock is expected to rise steadily over the coming years.
Xvivo Perfusion AB (publ) yearly Price Forecast Chart
Explore the yearly forecast chart for XVIPF, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Xvivo Perfusion AB (publ) over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for XVIPFForecasting details for XVIPF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Xvivo Perfusion AB (publ) Stock Forecast 2026
The forecast for Xvivo Perfusion AB (publ) (XVIPF) in 2026 suggests a price of $30.61, representing a 58.61% move from today’s price.
Average Target: $30.61
Market Outlook: bullish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.
Xvivo Perfusion AB (publ) Stock Forecast 2030
By 2030, Meyka AI projects XVIPF could trade near $33.65, showing a potential 74.36% compared to current levels.
Average Target: $33.65
Market Outlook: bullish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Xvivo Perfusion AB (publ).
Xvivo Perfusion AB (publ) 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for XVIPF points to a price around $34.28, which is a projected 77.63% move from today’s level.
Average Target: $34.28
Outlook: bullish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Xvivo Perfusion AB (publ)’s ability to maintain market leadership.